Mechanistically, Listerin directly binds to Toll‐like receptor 4 (TLR4) mRNA and facilitates the IRE1α‐mediated cleavage and degradation of TLR4 mRNA, leading to the alleviation of TLR4‐induced brain inflammation. Here, ERN1 is linked to brain inflammatory disease.